Showing results (281-290 of 623) with videos related to
Sort By:
Pageof 63
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2008
Protein expression profiling in esophageal adenocarcinoma patients indicates association of heat-shock protein 27 expression and chemotherapy responseRupert Langer, Katja Ott, Katja Specht, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 18, 2008
SPECT/CTAndreas K Buck, Stephan Nekolla, Sibylle Ziegler, et al.Oncotarget|July 1, 2014
Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCLKen Herrmann, Andreas K Buck, Tibor Schuster, et al.European Journal of Nuclear Medicine and Molecular Imaging|February 17, 2024
EANM guidance document: dosimetry for first-in-human studies and early phase clinical trialsCaroline Stokke, Silvano Gnesin, Johannes Tran-Gia, et al.European Urology|October 20, 2024
Novel Radiopharmaceuticals and Future of Theranostics in Genitourinary CancersMartina Sollini, Jeremie Calais, Arturo Chiti, et al.Nuclear Medicine Communications|September 12, 2018
Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124I PET/CT imagingRoel Wierts, Maurizio Conti, Anouk G G Claessen, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 3, 2021
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experienceBritta Heinze, Andreas Schirbel, Lukas Nannen, et al.Acta Biomaterialia|April 7, 2020
In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CTSebastian A Kollenda, Jasmin Klose, Torben Knuschke, et al.Cancer Research|August 10, 2012
FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapyZhoulei Li, Nicolas Graf, Ken Herrmann, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 4, 2020
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancerStefano Fanti, Karolien Goffin, Boris A Hadaschik, et al.Pageof 63